alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 438.360 Nonduplication of mandatory activities with Medicare or accreditation review. ( a ) *General rule.* Consistent with guidance issued by the Secretary under § 438.352, to avoid duplication the State may use information from a Medicare or private accreditation review of an MCO, PIHP, or PAHP to provide information for the annual EQR (described in § 438.350) instead of conducting one or more of the EQR activities described in § 438.358(b)(1)(i) through (iii) (relating to the validation of performance improvement projects, validation of performance measures, and compliance review) if the following conditions are met: ( 1 ) The MCO, PIHP, or PAHP is in compliance with the applicable Medicare Advantage standards established by CMS, as determined by CMS or its contractor for Medicare, or has obtained accreditation from a private accrediting organization recognized by CMS;
( 2 ) The Medicare or private accreditation review standards are comparable to standards established through the EQR protocols (§ 438.352) for the EQR activities described in § 438.358(b)(1)(i) through (iii); and
( 3 ) The MCO, PIHP, or PAHP provides to the State all the reports, findings, and other results of the Medicare or private accreditation review activities applicable to the standards for the EQR activities.
( b ) *External quality review report.* If the State uses information from a Medicare or private accreditation review in accordance with paragraph (a) of this section, the State must ensure that all such information is furnished to the EQRO for analysis and inclusion in the report described in § 438.364(a).
( c ) *Quality strategy.* The State must identify in its quality strategy under § 438.340 the EQR activities for which it has exercised the option described in this section, and explain the rationale for the State's determination that the Medicare review or private accreditation activity is comparable to such EQR activities, consistent with paragraph (a)(2) of this section.
[81 FR 27853, May 6, 2016, as amended at 89 FR 41279, May 10, 2024]
Order entered July 17, 2018

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-18-00807-CV

IN RE TOYOTA MOTOR SALES, U.S.A., INC. TOYOTA MOTOR CORPORATION, 

TOYOTA MOTOR NORTH AMERICA, INC., TOYOTA MOTOR ENGINEERING & 

MANUFACTURING NORTH AMERICA, INC., AND EDWARD MANTEY, Relators

Original Proceeding from the 134th Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC-16-15296

ORDER

Before Justices Lang-Miers, Fillmore, and Whitehill

Before the Court is relators’ emergency motion for temporary relief. The emergency 

motion is DENIED AS MOOT in light of the Court’s opinion of this date denying relators’ 

petition for writ of mandamus.

/s/ ROBERT M. FILLMORE 

JUSTICE
<PAGE>



EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. SS.1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report on Form 10-Q of Enzon
Pharmaceuticals, Inc. (the Company) for the period ended September 30, 2006 as
filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Craig A. Tooman, Executive Vice President, Finance, and Chief
Financial Officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

         1.    The Report fully complies with the requirements of Section 13(a)
               or15(d) of the Securities Exchange Act of 1934; and

         2.    The information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.


 November 2, 2006                          By: /s/Craig A. Tooman
                                               ---------------------------------
                                           Craig A. Tooman
                                           Executive Vice President, Finance and
                                           Chief Financial Officer
                                           (Principal Financial Officer)

         The foregoing certification is being furnished solely pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code) and is not being filed
as part of the Form 10-Q or as a separate disclosure document.

         A signed original of this written statement required by Section 906 has
been provided to Enzon Pharmaceuticals, Inc. and will be retained by Enzon
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.
Exhibit 23.2

            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Alfacell Corporation:

We consent to the incorporation by reference in the registration statements (No.
333-112865) on Form S-3 and (Nos. 33-81308, 333-110074 and 333-112866) on Form
S-8 of Alfacell Corporation of our report dated November 4, 2002, with respect
to the related statements of operations, stockholders' equity (deficiency), and
cash flows of Alfacell Corporation for the period from August 24, 1981 (date of
inception) to July 31, 2002, which report appears in the July 31, 2005 annual
report on Form 10-K of Alfacell Corporation. Our report dated November 4, 2002,
as it relates to the financial statements for the period from August 24, 1981
(date of inception) to July 31, 2002, is based on the report of other auditors
who have ceased operations as to the amounts included therein for the period
from August 24, 1981 (date of inception) to July 31, 1992.

Our report dated November 4, 2002 contains an explanatory paragraph that states
that the Company has suffered recurring losses from operations, has a working
capital deficit and has limited liquid resources which raise substantial doubt
about its ability to continue as a going concern. The financial statements do
not include any adjustments that might result from the outcome of that
uncertainty.


                                              /s/ KPMG LLP

                                              Short Hills, New Jersey
                                              October 10, 2005
#### § 423.664 Authority of hearing officer.

In exercising his or her authority, the hearing officer must comply with the provisions of title XVIII and related provisions of the Act, the regulations issued by the Secretary, and general instructions issued by CMS in implementing the Act.
HomeOffice of the SpokespersonPress Releases...Joint Statement: The United States and the United Arab Emirates Working Together on Climate Challenge

# 									Joint Statement: The United States and the United Arab Emirates Working Together on Climate Challenge							

Media Note

Office of the Spokesperson

April 5, 2021

At the conclusion of Special Presidential Envoy for Climate John Kerry’s visit to the United Arab Emirates, the two nations released the following statement:

*Begin text:*

The United States and the United Arab Emirates are committed to working together to take on the climate challenge. We believe decisive action can be an engine for economic growth and sustainable development.

We will work to strengthen the implementation of the Paris Agreement and promote the success of COP26 in Glasgow. Mindful of the importance and urgency of raising global climate ambition, we each intend to take steps to decarbonize our economies in line with our national circumstances and economic development plans, including reducing our emissions by 2030.

We will also cooperate closely to make new investments in financing decarbonization across both the Middle East and North Africa (MENA) region and the wider international community and help the most vulnerable adapt to the inevitable effects of climate change. In this regard, we are encouraged by new regional initiatives, such as the Green Middle East initiative by the Kingdom of Saudi Arabia.

We will particularly focus our joint efforts on renewable energy, hydrogen, industrial decarbonization, carbon capture and storage, nature-based solutions, and low-carbon urban design – exemplified by model cities like Masdar City, and the world’s largest single-site solar facility in Noor in Abu Dhabi. We take note of opportunities in the UAE, such as the world’s lowest solar power costs, and significant carbon capture investments.

We will partner with the global community to take the necessary steps to keep a Paris-aligned temperature limit within reach, including through country-specific enhancements to nationally determined contributions. We recognize the strong climate efforts of many leading companies and will work closely with the private sector to mobilize the investment and transformative mitigation and adaptation technologies needed to stem the climate crisis and support the economy.

We are encouraged by the conversations we held in Abu Dhabi with other countries in the region, which we believe inaugurated a new era of cooperation in the region for a future focused on prosperity through climate policy, investment, innovation, and sustainable economic growth.

*End text.*

Tags

Bureau of Near Eastern AffairsBureau of Oceans and International Environmental and Scientific AffairsClimate ChangeOffice of the SpokespersonOffice of the U.S. Special Presidential Envoy for ClimateUnited Arab Emirates

Back to Top
#### Dominic J. GRAPHIA v. SHERIFF’S PENSION AND RELIEF FUND et al.

No. 65016.

Supreme Court of Louisiana.

Sept. 4, 1979.

In re Dominic J. Graphia applying for writ of certiorari, First Circuit Court of Appeal. Parish of East Baton Rouge. 370 So.2d 1315.

Granted.
EXHIBIT 10.90

                              URT Industries, Inc.
                         1180 E. Hallandale Beach Blvd.
                            Hallandale, Florida 33009

                                                           April 14, 2000

Peaches Entertainment Corp.
1180 East Hallandale Beach Blvd.
Hallandale, Florida 33009

Gentlemen:

     It is  the  purpose  of  this  letter  to  confirm  the  agreement  of  URT
Industries,  Inc. ("URT") that the compensation payable by Peaches Entertainment
Corporation  ("PEC") to Allan Wolk,  pertaining  to the  services of Allan Wolk,
pursuant to the  agreement  dated  January 1, 1996  between URT and PEC, as such
agreement has previously been amended (the "Intercorporate Agreement"), shall be
$248,000  for the fiscal  year  ending  April 1,  2000.  Other than as set forth
immediately above, the  Intercorporate  Agreement shall remain in full force and
effect.

Please sign below to evidence our agreement.


Very truly yours,


                                                URT Industries, Inc.


By: /s/ Brian Wolk
    -------------------------
    Executive Vice-President

Agreed to and approved:

Peaches Entertainment Corporation

By: /s/ Jason Wolk
    -------------------------
    Executive Vice-President


                                      -55-
§ 455.105 Disclosure by providers: Information related to business transactions. ( a ) *Provider agreements.* A Medicaid agency must enter into an agreement with each provider under which the provider agrees to furnish to it or to the Secretary on request, information related to business transactions in accordance with paragraph (b) of this section.
( b ) *Information that must be submitted.* A provider must submit, within 35 days of the date on a request by the Secretary or the Medicaid agency, full and complete information about— ( 1 ) The ownership of any subcontractor with whom the provider has had business transactions totaling more than $25,000 during the 12-month period ending on the date of the request; and
( 2 ) Any significant business transactions between the provider and any wholly owned supplier, or between the provider and any subcontractor, during the 5-year period ending on the date of the request.
( c ) *Denial of Federal financial participation (FFP).* ( 1 ) FFP is not available in expenditures for services furnished by providers who fail to comply with a request made by the Secretary or the Medicaid agency under paragraph (b) of this section or under § 420.205 of this chapter (Medicare requirements for disclosure).
( 2 ) FFP will be denied in expenditures for services furnished during the period beginning on the day following the date the information was due to the Secretary or the Medicaid agency and ending on the day before the date on which the information was supplied.
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report on Form 10-Q of Enzon Pharmaceuticals,
Inc. (the Company) for the period ended March 31, 2011 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Ralph
del Campo, Chief Operating Officer of the Company, certify pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to my knowledge:

| |    |                                                                                                                                                       
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------
| | 1. | The Report fully complies with the requirements of Section 13(a) or
 15(d) of the Securities Exchange Act of 1934; and                                
| |    |                                                                                                                                                       
| | 2. | The information contained in the Report fairly presents, in all
 material respects, the financial condition and results of operations of the
 Company.

|            |                                                                       |  | 
|----------- | --------------------------------------------------------------------- |  | 
|May 6, 2011 | /s/Ralph del Campo                                                    | 
|            |                                                                       | 
|            | Ralph del CampoChief Operating Officer
 (Principal Executive Officer)

---
HomeOffice of the SpokespersonPress Releases...Moscow Mechanism Invoked by 45 OSCE States To Review Reported Abuses by Russia

# 									Moscow Mechanism Invoked by 45 OSCE States To Review Reported Abuses by Russia							

Press Statement

Ned Price, Department Spokesperson

March 3, 2022

With Ukraine’s agreement, the United States and 44 other countries have invoked the OSCE Moscow Mechanism.  This action will establish an expert mission to address our grave concerns regarding the humanitarian and human rights impacts on the people of Ukraine caused by Russia’s further invasion with the support of Belarus.  We have seen the troubling media reports of human rights abuses and violations of humanitarian law by Russia’s forces, including the mounting number of civilian casualties and extensive damage to civilian infrastructure.  The OSCE expert mission will work impartially to establish the facts and circumstances surrounding possible contraventions of OSCE commitments and violations and abuses of international human rights law and international humanitarian law by Russia’s forces.  The expert mission will prepare a report that will be shared with all OSCE participating States and relevant accountability mechanisms, including national, regional, and international courts and tribunals.  The United States and our partners will hold Russia and its forces accountable for all human rights abuses, violations of international humanitarian law, war crimes, and crimes against humanity they commit in Ukraine.

Tags

Bureau of Democracy, Human Rights, and LaborBureau of European and Eurasian AffairsHuman RightsOffice of the SpokespersonRussiaUkraineWar Crimes

Back to Top
§ 417.428 Marketing activities. ( a ) With the exception of § 422.2276 of this chapter, the procedures and requirements relating to marketing requirements set forth in subpart V of part 422 of this chapter also apply to Medicare contracts with HMOs and CMPs under section 1876 of the Act.
( b ) In applying those provisions, references to part 422 of this chapter must be read as references to this part, and references to MA organizations as references to HMOs and CMPs.
[75 FR 19802, Apr. 15, 2010]
§ 405.1124 Oral argument. A party may request to appear before the Council to present oral argument. ( a ) The Council grants a request for oral argument if it decides that the case raises an important question of law, policy, or fact that cannot be readily decided based on written submissions alone.
( b ) The Council may decide on its own that oral argument is necessary to decide the issues in the case. If the Council decides to hear oral argument, it tells the parties of the time and place of the oral argument at least 10 calendar days before the scheduled date.
( c ) In case of a previously unrepresented beneficiary, a newly hired representative may request an extension of time for preparation of the oral argument and the Council must consider whether the extension is reasonable.
( d ) The Council may also request, but not require, CMS or its contractor to appear before it if the Council determines that it may be helpful in resolving the issues in the case.
( e ) The Council will not draw any inference if CMS or a contractor decides not to participate in the oral argument.
[70 FR 11472, Mar. 8, 2005, as amended at 74 FR 65338, Dec. 9, 2009; 82 FR 5124, Jan. 17, 2017]
#### § 441.206 Documentation needed by the Medicaid agency.

FFP is not available in any expenditures for abortions or other medical procedures otherwise provided for under § 441.203 if the Medicaid agency has paid without first having received the certifications and documentation specified in that section.

[52 FR 47935, Dec. 17, 1987]
HomeOffice of the SpokespersonPress Releases...Deputy Secretary Verma Travels to Mexico

# 									Deputy Secretary Verma Travels to Mexico							

Media Note

Office of the Spokesperson

July 24, 2023

Deputy Secretary of State for Management and Resources Richard R. Verma will travel to Mexico City and Ciudad Juárez, Mexico, July 24-26. In Mexico City, he will join Homeland Security Advisor Dr. Elizabeth Sherwood-Randall at the second meeting of the Trilateral Fentanyl Committee, hosted by Mexican Secretary of Security Rosa Icela Rodríguez. This meeting will enhance coordination on combatting the synthetic drug threat, drug demand and public health, drug trafficking modes and methods, and illicit finance. Deputy Secretary Verma will also meet with Mexican government officials to discuss migration, forced displacement, and expanding access to lawful pathways. He will also travel to Ciudad Juárez to visit with migration stakeholders on both sides of the border.

Tags

Bureau of Western Hemisphere AffairsDeputy Secretary of State for Management and ResourcesDrug TraffickingDrugsMexicoOffice of the SpokespersonOfficial International Travel

Back to Top
#### Carl MOREIN et al. v. ALLSTATE INSURANCE COMPANY et al.

No. 64778.

Supreme Court of Louisiana.

Sept. 4, 1979.

In re Allstate Insurance Company applying for rehearing. Parish of Iberia. No. 38767.

Rehearing denied.
§ 421.302 Eligibility requirements for Medicare integrity program contractors. ( a ) CMS may enter into a contract with an entity to perform the functions described in § 421.304 if the entity meets the following conditions: ( 1 ) Demonstrates the ability to perform the Medicare integrity program contractor functions described in § 421.304. For purposes of developing and periodically updating a list of DME under § 421.304(e), an entity is deemed to be eligible to enter into a contract under the Medicare integrity program to perform the function if the entity is a carrier with a contract in effect under section 1842 of the Act.
( 2 ) Agrees to cooperate with the OIG, the DOJ, and other law enforcement agencies, as appropriate, including making referrals, in the investigation and deterrence of potential fraud and abuse of the Medicare program.
( 3 ) Complies with conflict of interest provisions in 48 CFR chapters 1 and 3, and is not excluded under the conflict of interest provision at § 421.310.
( 4 ) Maintains an appropriate written code of conduct and compliance policies that include, but are not limited to, an enforced policy on employee conflicts of interest.
( 5 ) Meets other requirements that CMS establishes.
( b ) A MAC as described in section 1874A of the Act may perform any or all of the functions described in § 421.304, except that the functions may not duplicate work being performed under a Medicare integrity program contract.
( c ) If a MAC performs any or all functions described in § 421.304, CMS may require the MAC to comply with any or all of the requirements of paragraph (a) of this section as a condition of its contract.
Editorial Note on Part 457
Editorial Note: Nomenclature changes to part 457 appear at 75 FR 48852, Aug. 11, 2010 and 77 FR 17213, 2013.

§ 457.203 Administrative and judicial review of action on State plan material. ( a ) *Request for reconsideration.* Any State dissatisfied with the Administrator's action on State plan material under § 457.150 may, within 60 days after receipt of the notice of final determination provided under § 457.160(a), request that the Administrator reconsider whether the State plan or plan amendment conforms with the requirements for approval.
( b ) *Notice of hearing.* Within 30 days after receipt of the request, the Administrator notifies the State of the time and place of a hearing to be held for the purpose of reconsideration.
( c ) *Hearing procedures.* The hearing procedures set forth in part 430, subpart D of this chapter govern a hearing requested under this section.
( d ) *Effect of hearing decision.* CMS does not delay the denial of Federal funds, if required by the Administrator's original determination, pending a hearing decision. If the Administrator determines that his or her original decision was incorrect, CMS will pay the State a lump sum equal to any funds incorrectly denied.
[66 FR 2674, Jan. 11, 2001]
§ 415.120 Conditions for payment: Radiology services. ( a ) *Services to beneficiaries.* The carrier pays for radiology services furnished by a physician to a beneficiary on a fee schedule basis only if the services meet the conditions for fee schedule payment in § 415.102(a) and are identifiable, direct, and discrete diagnostic or therapeutic services furnished to an individual beneficiary, such as interpretation of x-ray plates, angiograms, myelograms, pyelograms, or ultrasound procedures. The carrier pays for interpretations only if there is a written report prepared for inclusion in the patient's medical record maintained by the hospital.
( b ) *Services to providers.* The carrier does not pay on a fee schedule basis for physician services to the provider (for example, administrative or supervisory services) or for provider services needed to produce the x-ray films or other items that are interpreted by the radiologist. However, the intermediary pays the provider for these services in accordance with § 415.55 for provider costs; § 415.102(d)(2) for costs incurred by a physician, such as under a lease or concession agreement; or part 412 of this chapter for payment under PPS.